Psoriasis and Cardiovascular Risk: Correlation Between Psoriasis and Cardiovascular Functional Indices

Angiology - Tập 69 Số 1 - Trang 31-37 - 2018
Giuseppe Dattilo1, Egidio Imbalzano1, Matteo Casale1, Claudio Guarneri2, Francesco Borgia2, Stefania Mondello3, Pasqualina Laganà3, Pietro Romano1, Giuseppe Oreto1, Sarafinella Cannavò2
1Section of Cardiology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
2Section of Dermatology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
3Department of Biomedical, Dental Sciences and Morphological and Functional Images, University of Messina, Messina, Italy

Tóm tắt

Evidence suggests that psoriasis together with other cardiovascular (CV) risk factors is associated with increased vascular morbidity, but it is not clear whether psoriasis is an independent risk factor. Consecutive patients (n = 33; 35.6 ± 5.7 years; 13 females) with mild psoriasis (Psoriasis Area and Severity Index <10) without comorbidities and 33 healthy participants (36.3 ± 5.9 years; 15 females) were enrolled. Both groups underwent echocardiography, speckle tracking (2-dimensional strain echocardiography [2D-SE]), and pulse wave velocity (PWV) testing. Clinical and conventional echocardiographic characteristics were comparable between both groups. Global longitudinal strain (GLS) was significantly lower ( P = .002) in the psoriasis group (22.39% ± 2.28%) than in controls (24.15% ± 2.17%). The PWV was significantly lower ( P = .004) in controls (8.06 ± 1.68 m/s) than in the psoriasis group (9.23 ± 1.53 m/s). Significant correlations between GLS and disease duration ( r = −.66, P < .0001) and between GLS and patient age at diagnosis ( r = .48, P = .0043) were found. Psoriasis may be an independent CV risk factor, causing cardiac and vascular impairment. Both 2D-SE and PWV may be useful tools for the screening of CV risk in these patients.

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(07)61128-3

10.1056/NEJMra041320

10.1111/j.1468-3083.2009.03564.x

10.2174/1381612820666140417105323

10.1016/j.atherosclerosis.2013.10.023

10.1001/jama.296.14.1735

10.1038/sj.jid.5701213

10.1111/bjd.12631

10.1111/j.1468-3083.2011.04410.x

10.1016/j.clindermatol.2013.11.001

10.1007/s12016-012-8308-0

10.1001/archdermatol.2011.119

Imbalzano E, 2014, Expertl Clin Cardiol, 20, 2729

10.1016/j.jacc.2005.08.073

10.1161/CIRCULATIONAHA.107.748491

10.1016/j.echo.2011.01.015

10.1016/j.ijcard.2016.04.035

10.1161/01.HYP.37.5.1236

10.1088/0967-3334/28/5/010

10.1016/j.jacc.2010.12.017

10.3109/10641963.2012.746354

10.1093/eurheartj/ehl254

Choi BG, 2016, Angiology, 000331971665228

10.1016/j.jacc.2013.09.063

10.1007/s10554-015-0733-8

10.1177/0003319714568790

10.1016/j.echo.2005.10.005

10.1001/archdermatol.2009.94

10.1016/0190-9622(95)91336-X

10.1001/archderm.135.12.1490

Dattilo G, 2014, Minerva Cardioangiol, 62, 119

10.1177/0003319714527339

10.1371/journal.pone.0036342

10.1111/j.1365-4632.2011.05430.x

Guven ASS, 2003, T Klin J Cardiol, 16, 77

10.3109/08037051.2010.505322

10.1016/j.pcad.2006.08.008

10.1016/j.ijcard.2013.12.081

10.1016/j.jacc.2008.02.040

10.1111/ijd.12703

10.1007/s00380-014-0490-y

10.1016/j.atherosclerosis.2015.05.007

Yiu KH, 2011, Br J Dermatol, 164, 514

10.1177/0003319713485805

10.1111/bjd.12525

Thông tin
Thông tin xuất bản

Angiology

Tập 69 Số 1

31-37

Thông tin tác giả